Published April 21, 2026
Drug Pipeline Insights: New Drugs
Our 2026 Q1 New Drugs Insights demonstrates how the the latest round of new drug approvals and submissions, from rare disease breakthroughs to cutting-edge oncology therapies, is set to res…
Read more about Drug Pipeline Insights: New DrugsPublished April 21, 2026
Drug Pipeline Insights: Generic Pharmaceuticals
Our 2026 Q1 Generics Insights highlights a wave of high-value generic launches—including major diabetes and oncology drugs—signaling one of the most commercially impactful years for pharmacy in over …
Read more about Drug Pipeline Insights: Generic PharmaceuticalsPublished April 21, 2026
Drug Pipeline Spotlight: Semaglutide
Our Drug Pipeline Spotlight on Semaglutide explores the explosive growth of GLP-1 therapies like Ozempic, Wegovy, and Rybelsus, the anticipated entry of generics in 2026, and what it all means for ph…
Read more about Drug Pipeline Spotlight: SemaglutidePublished April 9, 2026
From the Desk of the CEO - 2026 Q1 Update
Neighbourhood Pharmacies releases its Q1 2026 From the Desk of the CEO letter.
Read more about From the Desk of the CEO - 2026 Q1 UpdatePublished February 19, 2026
Pharmacy Services and Remuneration Report
Our February 2026 (V2026-1) publication features a brand new clean look, as well as multiple content updates: significant changes in NS as a result of new service and tariff agreements, the incl…
Read more about Pharmacy Services and Remuneration ReportPublished January 22, 2026
2025 Annual Impact Report
2025 marked a pivotal year for Neighbourhood Pharmacies. As we launched the first year of our Prescription for Success: 2025–2029 —and celebrated 30 years as an Association—we translated st…
Read more about 2025 Annual Impact Report